BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23432949)

  • 1. Concurrent rearrangements of BCL2, BCL3, and BCL11A genes in atypical chronic lymphocytic leukemia.
    Podgornik H; Pretnar J; Skopec B; Andoljšek D; Černelč P
    Hematology; 2014 Jan; 19(1):45-8. PubMed ID: 23432949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic 2; 18 and 18; 22 translocation in chronic lymphocytic leukemia with juxtaposition of bcl-2 and immunoglobulin light chain genes.
    Tashiro S; Takechi M; Asou H; Takauchi K; Kyo T; Dohy H; Kikuchi M; Kamada N; Tsujimoto Y
    Oncogene; 1992 Mar; 7(3):573-7. PubMed ID: 1549371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of t(11;14) in a patient with chronic lymphocytic leukemia carrying both t(14;19)(q32;q13.1) and +12.
    Nishida Y; Takeuchi K; Tsuda K; Ugai T; Sugihara H; Yamakura M; Takeuchi M; Matsue K
    Eur J Haematol; 2013 Aug; 91(2):179-82. PubMed ID: 23581835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse B-cell tumors associated with t(14;19)(q32;q13)/IGH::BCL3 identified by G-banding and fluorescence in situ hybridization.
    Ohno H; Maekawa F; Hayashida M; Nakagawa M; Fukutsuka K; Matsumura M; Takeoka K; Maruyama W; Ukyo N; Sumiyoshi S; Tanaka Y; Haga H
    J Clin Exp Hematop; 2024; 64(1):21-31. PubMed ID: 38538317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel, clonally stable, somatic mutations targeting transcription factors PAX5 and NKX2-3, the epigenetic regulator LRIF1, and BRAF in a case of atypical B-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21).
    Burlet B; Ramla S; Fournier C; Abrey-Recalde MJ; Sauter C; Chrétien ML; Rossi C; Duffourd Y; Ragot S; Buriller C; Tournier B; Chapusot C; Nadal N; Racine J; Guy J; Bailly F; Martin L; Casasnovas O; Bastie JN; Caillot D; Albuisson J; Broccardo C; Thieblemont C; Delva L; Maynadié M; Aucagne R; Callanan MB
    Cold Spring Harb Mol Case Stud; 2021 Feb; 7(1):. PubMed ID: 33608382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lymphocytic leukemia FISH panel: impact on diagnosis.
    Nelson BP; Gupta R; Dewald GW; Paternoster SF; Rosen ST; Peterson LC
    Am J Clin Pathol; 2007 Aug; 128(2):323-32. PubMed ID: 17638669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of somatic hypermutation of IG V(H) genes in lymphoid malignancies with t(2;14)(p13;q32) translocation involving the BCL11A gene.
    Küppers R; Sonoki T; Satterwhite E; Gesk S; Harder L; Oscier DG; Tucker PW; Dyer MJ; Siebert R
    Leukemia; 2002 May; 16(5):937-9. PubMed ID: 11986957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course.
    Put N; Van Roosbroeck K; Konings P; Meeus P; Brusselmans C; Rack K; Gervais C; Nguyen-Khac F; Chapiro E; Radford-Weiss I; Struski S; Dastugue N; Gachard N; Lefebvre C; Barin C; Eclache V; Fert-Ferrer S; Laibe S; Mozziconacci MJ; Quilichini B; Poirel HA; Wlodarska I; Hagemeijer A; Moreau Y; Vandenberghe P; Michaux L;
    Ann Hematol; 2012 Jun; 91(6):863-73. PubMed ID: 22205151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinico-pathological impact of cytogenetic subgroups in B-cell chronic lymphocytic leukemia: experience from India.
    Amare PS; Gadage V; Jain H; Nikalje S; Manju S; Mittal N; Gujral S; Nair R
    Indian J Cancer; 2013; 50(3):261-7. PubMed ID: 24061469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.
    Fang H; Reichard KK; Rabe KG; Hanson CA; Call TG; Ding W; Kenderian SS; Muchtar E; Schwager SM; Leis JF; Chanan-Khan AA; Slager SL; Braggio E; Smoley SA; Kay NE; Shanafelt TD; Van Dyke DL; Parikh SA
    Am J Hematol; 2019 Mar; 94(3):338-345. PubMed ID: 30575108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation.
    Martín-Subero JI; Ibbotson R; Klapper W; Michaux L; Callet-Bauchu E; Berger F; Calasanz MJ; De Wolf-Peeters C; Dyer MJ; Felman P; Gardiner A; Gascoyne RD; Gesk S; Harder L; Horsman DE; Kneba M; Küppers R; Majid A; Parry-Jones N; Ritgen M; Salido M; Solé F; Thiel G; Wacker HH; Oscier D; Wlodarska I; Siebert R
    Leukemia; 2007 Jul; 21(7):1532-44. PubMed ID: 17495977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study.
    McKeithan TW; Takimoto GS; Ohno H; Bjorling VS; Morgan R; Hecht BK; Dubé I; Sandberg AA; Rowley JD
    Genes Chromosomes Cancer; 1997 Sep; 20(1):64-72. PubMed ID: 9290956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare double-hit with two translocations involving IGH both, with BCL2 and BCL3, in a monoclonal B-cell lymphoma/leukemia.
    Alpatov R; Carstens B; Harding K; Jarrett C; Balakhani S; Lincoln J; Brzeskiewicz P; Guo Y; Ohene-Mobley A; LeRoux J; McDaniel V; Meltesen L; Minka D; Patel M; Manavi C; Swisshelm K
    Mol Cytogenet; 2015; 8():101. PubMed ID: 26719766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the BCL3 gene in two patients with chronic lymphocytic leukemia.
    Yabumoto K; Ohno H; Doi S; Edamura S; Arita Y; Akasaka T; Matsumoto J; Kadowaki N; Fukuhara S; Okuma M
    Int J Hematol; 1994 Apr; 59(3):211-8. PubMed ID: 8011990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
    Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
    Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rearrangement of the 5' cluster region of the BCL2 gene in lymphoid neoplasm: a summary of nine cases.
    Yabumoto K; Akasaka T; Muramatsu M; Kadowaki N; Hayashi T; Ohno H; Fukuhara S; Okuma M
    Leukemia; 1996 Jun; 10(6):970-7. PubMed ID: 8667654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
    Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
    Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation.
    Cuneo A; Bigoni R; Negrini M; Bullrich F; Veronese ML; Roberti MG; Bardi A; Rigolin GM; Cavazzini P; Croce CM; Castoldi G
    Cancer Res; 1997 Mar; 57(6):1144-50. PubMed ID: 9067285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. t(18;22)(q21;q11) with rearrangement of BCL2 as a possible secondary change in a lymphocytic lymphoma.
    Leroux D; Hillion J; Monteil M; Le Marc'hadour F; Jacob MC; Sotto JJ; Larsen CJ
    Genes Chromosomes Cancer; 1991 May; 3(3):205-9. PubMed ID: 1868035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.